Literature DB >> 23228877

A diseased bone marrow fuels atherosclerosis in diabetes.

Gian Paolo Fadini1.   

Abstract

Diabetes accelerates atherosclerosis through shortage of vascular regenerative cells derived from the bone marrow (BM). In addition, diabetes shifts the differentiation of BM progenitor cells to pro-calcific and smooth muscle phenotypes. In a paper published in Atherosclerosis, Fledderus et al. demonstrate that the accelerated atherosclerosis in diabetic ApoE(-/-) mice is associated with an increased amount of BM-derived smooth muscle cells in the plaques. The role of ApoE in the regulation of vascular BM progenitors may explain inconsistencies in the literature on the contribution of extraparietal cells to atherosclerotic lesions. Herein, the pathophysiological meaning of a deranged kinetic of smooth muscle progenitor cells in diabetes is discussed.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23228877     DOI: 10.1016/j.atherosclerosis.2012.11.015

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  2 in total

Review 1.  A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications.

Authors:  G P Fadini
Journal:  Diabetologia       Date:  2013-10-31       Impact factor: 10.122

Review 2.  The pleiotropic cardiovascular effects of dipeptidyl peptidase-4 inhibitors.

Authors:  Angelo Avogaro; Gian Paolo Fadini
Journal:  Br J Clin Pharmacol       Date:  2018-06-03       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.